Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $14.74, but opened at $13.98. Reckitt Benckiser Group shares last traded at $13.97, with a volume of 10,448 shares.
Analyst Upgrades and Downgrades
RBGLY has been the topic of several recent analyst reports. Zacks Research raised Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a report on Friday, August 28th. Jefferies Financial Group raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Tuesday, July 21st. The Goldman Sachs Group upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, October 7th. BNP Paribas Exane lowered Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a research note on Wednesday, September 2nd. Finally, UBS Group restated a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Reckitt Benckiser Group has a consensus rating of “Moderate Buy”.
Check Out Our Latest Analysis on RBGLY
Reckitt Benckiser Group Trading Up 0.7%
The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.40 and a current ratio of 0.59. The stock’s 50-day moving average price is $13.88 and its 200-day moving average price is $14.18.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc, now operating under the Reckitt name, is a global consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets branded products intended to support personal health, household cleanliness and everyday hygiene.
Its portfolio includes consumer health brands such as Nurofen, Strepsils, Gaviscon, Mucinex and Durex, as well as hygiene and household brands including Dettol, Lysol, Finish and Harpic. Reckitt sells products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other distribution channels.
The company was formed in 1999 through the merger of the British household-products manufacturer Reckitt & Colman and the Dutch company Benckiser.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
